Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
3.070
-0.050 (-1.60%)
Sep 10, 2026, 3:04 PM CST
SHE:300111 Revenue
Zhejiang Sunflower Great Health had revenue of 54.01M CNY in the quarter ending June 30, 2026, a decrease of -25.18%. This brings the company's revenue in the last twelve months to 235.69M, down -25.71% year-over-year. In the year 2025, Zhejiang Sunflower Great Health had annual revenue of 271.53M, down -17.81%.
Revenue (ttm)
235.69M
Revenue Growth
-25.71%
P/S Ratio
17.04
Revenue / Employee
777.84K
Employees
303
Market Cap
4.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 271.53M | -58.83M | -17.81% |
| Dec 31, 2024 | 330.37M | -8.05M | -2.38% |
| Dec 31, 2023 | 338.42M | 2.56M | 0.76% |
| Jan 1, 2023 | 335.86M | 38.57M | 12.97% |
| Jan 1, 2022 | 297.29M | 10.33M | 3.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Tibet Weixinkang Medicine | 1.13B |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Newland Pharmaceutical | 710.55M |
| Shanghai Xiao Fang Pharmaceutical | 537.42M |
| Shaanxi Kanghui Pharmaceutical | 429.09M |